Cargando…

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM

BACKGROUND: This pooled analysis investigated the prognostic value of depth of response in two cohorts of patients with BRAF(V600)-mutated metastatic melanoma treated with vemurafenib or cobimetinib plus vemurafenib. METHODS: The data were pooled from BRIM-2, BRIM-3, BRIM-7 and coBRIM. Association o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Karl D., Larkin, James, Ribas, Antoni, Flaherty, Keith T., McArthur, Grant A., Ascierto, Paolo A., Dréno, Brigitte, Yan, Yibing, Wongchenko, Matthew, McKenna, Edward, Zhu, Qian, Mun, Yong, Hauschild, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889491/ https://www.ncbi.nlm.nih.gov/pubmed/31417188 http://dx.doi.org/10.1038/s41416-019-0546-y

Ejemplares similares

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF(V600) Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study
por: Ascierto, Paolo A., et al.
Publicado: (2021)

Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study
por: de la Cruz-Merino, Luis, et al.
Publicado: (2017)

Physicists brim with confidence
Publicado: (2000)

The best of SBP-BRiMS
por: Carley, Kathleen M.
Publicado: (2020)

coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF(V600) mutation–positive patients with unresectable locally advanced or metastatic melanoma (NCT01689519)
por: Ascierto, Paolo A, et al.
Publicado: (2015)

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma
por: Yan, Yibing, et al.
Publicado: (2014)

On the Treatment of Labour Delayed by Obstruction at the Pelvic Brim
por: Sloan, Samuel
Publicado: (1886)

On the Treatment of Labour Delayed by Obstruction at the Pelvic Brim
por: Sloan, Samuel
Publicado: (1886)

The Causation of the Movements of the Head at the Brim of the Rickety Pelvis
por: Hart, D. Berry
Publicado: (1882)

Vemurafenib in patients with BRAF(V600) mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study
por: Chapman, P B, et al.
Publicado: (2017)

On the Causation of the Movements of the Head at the Brim of the Rickety Pelvis (with Woodcuts)
por: Hart, D. Berry
Publicado: (1882)

Ectopic Kidney on the Pelvic Brim with Rare Anomalies in the Vascular Arrangement
por: Basu, Sunil Krishna
Publicado: (1953)

Demonstration of a New Method of Measuring the Pelvic Brim by Radiography
por: M'Kendrick, Archibald, et al.
Publicado: (1912)

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAF(V600)- mutated melanoma (BRIM7)
por: Puzanov, Igor, et al.
Publicado: (2014)

On the Comparative Value of the Long Forceps and Turning in Cases of Contracted Pelvic Brim: With Cases
por: Milne, Alexander
Publicado: (1867)

Unilateral Ureteric Endometriosis at the Pelvic Brim Resulting in Complete Loss of Renal Function
por: Tanaka, Keisuke, et al.
Publicado: (2019)

Successful side-viewing endoscopic hemoclipping for Dieulafoy-like lesion at the brim of a periampullary diverticulum
por: Lee, Wan Sik, et al.
Publicado: (2010)

On the Set of the Pelvis in the Body (Variations in the Inclination of the Brim Apart from Posture), and Its Obstetrical Significance
por: Barbour, A. H. Freeland
Publicado: (1900)

Safe Childbirth—The Three Essentials—1. Round Brim. 2. Flexible Joints. 3. Natural Posture
Publicado: (1937)

The Effect of Lateralization of a Pelvic Brim Plate on the Fixation of an Anterior Column Fracture: A Biomechanical Analysis
por: Gökgöz, Mehmet Burak, et al.
Publicado: (2022)

Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme
por: Gunn, H., et al.
Publicado: (2021)

Case of Porro-Müller Operation in a Labour Obstructed by a Large Dermoid Tumour Adherent to the Posterior Aspect of the Brim of the Pelvis
por: Macdonald, Angus
Publicado: (1885)

Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials
por: Ascierto, Paolo A., et al.
Publicado: (2020)

Two Cases in Which Turning Could Not Be Accomplished, in Consequence of the Head of the Child Remaining Firmly Fixed at the Brim of the Pelvis, Preventing the Breech Coming down
por: Wilson, James
Publicado: (1855)

Learning PHP 7: learn the art of PHP programming through this example-rich book filled to the brim with tutorials every PHP developer needs to know
por: Lopez, Antonio (software engineer)
Publicado: (2016)

Social, cultural, and behavioral modeling: 11th international conference, SBP-BRIMS 2018, Washington, DC, USA, July 10-13, 2018, proceedings
por: Thomson, Robert, et al.
Publicado: (2018)

Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial
por: Gunn, H., et al.
Publicado: (2017)

Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF(V600) mutation–positive melanoma
por: Dréno, Brigitte, et al.
Publicado: (2018)

Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report
por: Iafolla, Marco AJ, et al.
Publicado: (2019)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022)

Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials
por: Hopkins, Ashley M., et al.
Publicado: (2020)

Ocular Changes in Metastatic Melanoma Patients Treated with MEK Inhibitor Cobimetinib and BRAF Inhibitor Vemurafenib
por: Gavric, Ana Ursula, et al.
Publicado: (2018)

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
por: Álamo, Mª del Carmen, et al.
Publicado: (2021)

Vemurafenib- and Cobimetinib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Metastatic Melanoma
por: Al-Saedy, Miriam, et al.
Publicado: (2023)

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation
por: Simeone, Ester, et al.
Publicado: (2021)

The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib
por: Medina, Theresa M, et al.
Publicado: (2016)

Estimated Cost-effectiveness of Atezolizumab Plus Cobimetinib and Vemurafenib for Treatment of BRAF V600 Variation Metastatic Melanoma
por: Cai, Chao, et al.
Publicado: (2021)

Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients
por: Daud, Adil, et al.
Publicado: (2017)

SK119, a Novel Shikonin Derivative, Leads to Apoptosis in Melanoma Cell Lines and Exhibits Synergistic Effects with Vemurafenib and Cobimetinib
por: Kretschmer, Nadine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4cshmh7f06ct6l53gj37orji55